AstraZeneca AZN1.72%increase; green up pointing triangle reported mixed results from three late-stage clinical trials of an experimental treatment for a rare metabolic disease, but remains confident ...

Britain's most valuable company said its experimental lung disease medicine met its target in two late-stage clinical trials. The respiratory treatment Tozorakimab, reduced flare-ups of chronic ...

After a big investment earmarked for the US last year, AstraZeneca now intends to invest $15 billion in China, reflecting its strategic focus. AZN has meant to expand in the market for some time, most ...

As AstraZeneca kicks off the third year of its hockey-themed “Get Body Checked Against Cancer” campaign, the pharma has tapped two celebs known for their work both on and off the ice. Actor Joshua ...

AstraZeneca’s chief executive on Tuesday teased the prospect of a weight-loss drug in development that the company moved into late-stage trials. The company said it’s starting a Phase III program on ...

AstraZeneca Plc expects profit to grow further this year, boosted by sales of its cancer drugs as it works to offset a patent expiry of a blockbuster diabetes medicine. Earnings per share, excluding ...

AstraZeneca announced forecast-beating revenue on Tuesday. AstraZeneca's chief executive on Tuesday teased the prospect of a weight-loss drug in development that the company moved into late-stage ...

AstraZeneca is expanding its prospects in cardiometabolic disease, paying $1.2 billion to begin a partnership on eight programs that include obesity drug candidates with potential advantages over ...

AstraZeneca (AZN) on Thursday announced a $15B investment in China through 2030 to expand medicines manufacturing and R&D. The investment, announced during the UK Prime Minister’s official visit to ...

AstraZeneca Plc (NASDAQ: AZN) said Tuesday it will voluntarily delist its American Depositary Shares and certain guaranteed debt securities from the Nasdaq as it transitions to a direct stock listing ...

(RTTNews) - AstraZeneca PLC (AZN, AZN.L, ZEG.DE, AZN.ST) issued notice of the voluntary withdrawal from listing on The Nasdaq Stock Market of its American Depositary Shares, or the ADSs and debt ...